bovnews11m
Intra-Cellular Therapies Inc (ITCI) Reported a -19.82% Operating Margin Last Year—What’s the Real Story?
Intra-Cellular Therapies Inc (ITCI) stock saw a decline, ending the day at $126.9 which represents a decrease of $-0.29 or -0.23% from the prior close of $127.19. The stock opened at $127.24 and ...
JPMorgan lifts Primo Brands stock to $38 from $33, keeps Overweight
JPMorgan has updated its outlook on Primo Brands Corp. (NYSE: PRMB), raising the price target to $38.00 from the previous $33.00, while maintaining an Overweight rating on the company's shares.
KeyBanc raises Spotify stock target to $675, keeps Overweight rating
KeyBanc Capital Markets adjusted its outlook on Spotify Technology SA (NYSE:SPOT), increasing the price target to $675 from the previous $600, while maintaining an Overweight rating on the company's ...